{
  "url": "https://openlegislation.uk/eu-regulation-2015-1041/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2015-1041/annex.json",
  "legislation": "eur/2015/1041",
  "legislation_title": "Commission Regulation (EU) 2015/1041 of 30 June 2015 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2015-1041",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": "Rejected health claims",
  "text": "Application — Relevant provisions of Regulation (EC) No 1924/2006\nNutrient, substance, food or food category\nClaim\nEFSA opinion reference\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nCitrulline-malate\nMaintenance of ATP levels through reduction of lactates in excess for an improved recovery from muscle fatigue.\nQ-2013-00659\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nOlive (Olea europaea L.) leaf water extract\nDaily intake of supplemental olive leaf extract polyphenols contributes to the reduction of the blood glucose rise after meals.\nQ-2013-00783\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nPacran®\nPacran® helps to inhibit the adhesion of P-fimbriated E. coli to the urinary tract cells.\nQ-2013-00889\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nA combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104\nImproves intestinal comfort.\nQ-2013-00892\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nA combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104\nRegulates your (intestinal) transit.\nQ-2013-00893\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nA combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate\nContributes to the reduction of the blood glucose rise when consumed together with a carbohydrate rich meal.\nQ-2013-00756\nArticle 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.\nA combination of lutein and zeaxanthin\nLutein together with zeaxanthin helps maintain clarity and contrast of sight in bright light conditions.\nQ-2013-00875",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2015/1041/annex",
    "retrieved_at": "2026-11-01T14:46:36.799455+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}